Retirement Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$5.03K Hold
320
﹤0.01% 563
2023
Q4
$5.18K Hold
320
﹤0.01% 530
2023
Q3
$3.94K Hold
320
﹤0.01% 509
2023
Q2
$5.14K Hold
320
﹤0.01% 502
2023
Q1
$6K Hold
320
﹤0.01% 469
2022
Q4
$3K Hold
320
﹤0.01% 494
2022
Q3
$3K Hold
320
﹤0.01% 373
2022
Q2
$3K Hold
320
﹤0.01% 592
2022
Q1
$4K Hold
320
﹤0.01% 573
2021
Q4
$11K Hold
320
﹤0.01% 415
2021
Q3
$15K Hold
320
0.01% 345
2021
Q2
$14K Hold
320
0.01% 370
2021
Q1
$15K Hold
320
0.01% 426
2020
Q4
$17K Buy
320
+70
+28% +$3.16K 0.01% 374
2020
Q3
$9K Hold
250
0.01% 430
2020
Q2
$8K Buy
+250
New +$6.93K 0.01% 409
2019
Q4
$7K Buy
+250
New +$5.95K ﹤0.01% 414

Other funds holding NEO

Retirement Group's NEO Position: Q1 2024 in Review

Retirement Group held its NeoGenomics (NEO) position steady in Q1 2024 at 320 shares worth $5.03K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

Retirement Group first reported a position in NEO in Q4 2019 and has held it in 17 quarters since. The position peaked at $17K in Q4 2020. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Retirement Group held 320 shares of NeoGenomics worth $5.03K as of Q1 2024.
  • Retirement Group left its NeoGenomics share count unchanged in Q1 2024.
  • NeoGenomics made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #563 holding.
  • Retirement Group first reported a position in NeoGenomics in Q4 2019 and has held it in 17 quarters since.
  • Retirement Group's NeoGenomics position peaked at $17K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.